Life Sciences Pulse

Targeting growth equity investments in highly innovative life sciences businesses

The strategy seeks to invest in companies operating in specific areas of innovation, including therapeutics, diagnostics, and life sciences tools. By leveraging Sands Capital’s global research platform to source, assess, and structure investment opportunities, Sands Capital partners with pioneers in the expanding class of innovative life sciences businesses.

As of October 1, 2021, the firm was redefined to be the combination of Sands Capital Management, LLC and Sands Capital Ventures, LLC. The two investment advisers are combined to be one firm for GIPS® purposes and are doing business as Sands Capital. Sands Capital operates as a distinct business organization, retains discretion over the assets between the two registered investment advisers, and has autonomy over the total investment decision making process.

Our Investment Focus

In addition to the six criteria that guide all investment decisions at Sands Capital, Life Sciences Pulse invests in businesses that fit the following criteria:

Sector

Innovative life sciences business who are leaders in therapeutics,  diagnostics, and life sciences tools

Stage

Businesses with meaningful clinical data, proof of concept data, and/or promising business models

Geography

Targeting major innovation hubs around the globe

Concentration

$15 million – $30 million target investment size per company

Portfolio Businesses

Strategy Team

A bold mission requires a strong team. We sought out individuals who share our passion and have assembled a deep and diverse bench of investment, legal, operational, and financial personnel to execute on our mission.

Parker Cassidy

Parker Cassidy

Partner

Daniel H. Cheng

Daniel H. Cheng

Sr. Research Analyst

Michael J. Ginder, CFA

Michael J. Ginder, CFA

Research Analyst

Andrew P. Giordano

Andrew P. Giordano

Managing Director, Business Development and Client Relations

Jennifer A. Goldsmith

Jennifer A. Goldsmith

Sr. Research Analyst
Director, Research Associate Program

Jonathan P. Goodman

Jonathan P. Goodman

General Counsel

Yolande J. Hanlan

Yolande J. Hanlan

Director, Sr. Counsel

Jake Merrill, CFA

Jake Merrill, CFA

Principal

Ian Ratcliffe

Ian Ratcliffe

Executive Managing Partner
Executive Managing Director

Frank M. Sands, CFA

Frank M. Sands, CFA

Chief Investment Officer
Chief Executive Officer

Erin Soule, CPA

Erin Soule, CPA

Director of Finance & Operations

Stephen Zachary, PhD

Stephen Zachary, PhD

Managing Partner